■ 英語タイトル：Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0199 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：110 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global cephalosporin market size reached US$ 18.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.83% during 2023-2028.

Cephalosporins are beta-lactam antibiotics that function in the way similar to penicillin. These broad-spectrum drugs help in treating numerous bacterial infections such as pneumonia, kidney infections, bone infections, meningitis and various sexually transmitted diseases (STDs). There are currently five generations of cephalosporin drugs available in the market with a slight difference in their antibacterial spectrum. These medicines are also differentiated on the basis their administration, excretion, absorption and the duration of the effect of cephalosporin on the body. There are two ways to administer cephalosporin drugs, namely, oral and intravenous (IV). A course of oral cephalosporins is generally used for curing minor infections that are easy to treat such as strep throat. Whereas, IVs are utilized for more severe infections, like meningitis, as these medicines reach tissues quickly than those administered orally.

At present, the rapidly increasing water and air pollution are the primary reasons for the prevalence of infectious diseases across the globe. This has provided a boost to the demand for cephalosporin drugs worldwide. Other than this, various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents. The formation of these partnerships is expected to play a significant role in the growth of the cephalosporin market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cephalosporin market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on generation, route of administration and application.

Breakup by Generation:

First Generation
Second Generation
Third Generation
Fourth Generation
Fifth Generation

Breakup by Route of Administration:

Injection
Oral

Breakup by Application:

Respiratory Tract
Skin Infection
Ear Infection
Urinary Tract Infection
Sexually Transmitted Infection
Others

Breakup by Region:

Asia Pacific
Europe
North America
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Sun Pharmaceutical Industries Limited, etc.

Key Questions Answered in This Report
1. What was the size of the global cephalosporin market in 2022?
2. What is the expected growth rate of the global cephalosporin market during 2023-2028?
3. What are the key factors driving the global cephalosporin market?
4. What has been the impact of COVID-19 on the global cephalosporin market?
5. What is the breakup of the global cephalosporin market based on the generation?
6. What is the breakup of the global cephalosporin market based on the route of administration?
7. What are the key regions in the global cephalosporin market?
8. Who are the key players/companies in the global cephalosporin market?

■ 英語タイトル：Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0195 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：110 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global cardiovascular implants market size reached US$ 24.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 35.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.

Cardiovascular implants are medical devices used to treat cardiovascular disorders, including heart failure, myocardial infarction, peripheral arterial, aortic disease, and coronary artery diseases. They remain inside the body of a patient for the proper functioning of the heart and blood vessels. They assist in relieving symptoms of a slow and irregular heart rhythm. They consist of a transventricular splint with epicardial pads adjusted to decrease the LV radius, which produces the left ventricle to become smaller and energetically efficient. They can recognize a severe heart rhythm and transmit messages to the heart for maintaining the heart rhythm.

Cardiovascular Implants Market Trends:
The growing cases of heart failure on account of the increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors positively influencing the demand for cardiovascular implants worldwide. It can also be attributed to sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses. Moreover, the rising aging population, which is more prone to medical conditions, along with significant improvements in the healthcare infrastructure, is contributing to the market growth. In addition, increasing preferences for minimally invasive surgeries (MIS) due to their associated benefits is driving the market. Apart from this, the integration of artificial intelligence (AI), predictive analytics, and advanced algorithms for early detection of heart disease, treating strokes faster, and enhancing diagnostic radiology capabilities are creating a positive outlook for the market. Besides this, the rising public awareness about advancements in medical technology, and extensive research and development (R&D) activities, are offering lucrative growth opportunities to industry investors.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, material, procedure type and indication.

Breakup by Product Type:

Coronary Stent
ICD
Heart Valve
Implanted Cardiac Pacemaker
CRT Device
Peripheral Stent

ICD dominates the market as it assists in recording, reporting, and monitoring diseases.

Breakup by Material:

Metals and Alloys
Polymers
Biological Materials

Based on the material, the market has been segmented into metals and alloys, polymers and biological materials.

Breakup by Procedure Type:

Angioplasty
Open Heart Surgery

Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery.

Breakup by Indication:

Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Congestive Heart Failure
Others

Arrhythmias exhibit a clear dominance in the market as they facilitate the symptoms of irregular heartbeat and fluttering in the chest.

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

North America holds the majority of the global cardiovascular implants market share due to the well-established healthcare infrastructure in the region.

Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.

Key Questions Answered in This Report
1. What was the size of the global cardiovascular implants market in 2022?
2. What is the expected growth rate of the global cardiovascular implants market during 2023-2028?
3. What are the key factors driving the global cardiovascular implants market?
4. What has been the impact of COVID-19 on the global cardiovascular implants market?
5. What is the breakup of the global cardiovascular implants market based on the product type?
6. What is the breakup of the global cardiovascular implants market based on the indication?
7. What are the key regions in the global cardiovascular implants market?
8. Who are the key players/companies in the global cardiovascular implants market?

■ 英語タイトル：Cardiac Holter Monitor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0194 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：111 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global cardiac holter monitor market size reached US$ 435.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 606.8 Million by 2028, exhibiting a growth rate (CAGR) of 5.39% during 2023-2028.

A holter monitor is a battery-operated electrocardiography (ECG) device which assists in measuring and recording the heart’s activity for 24 to 48 hours. It comprises a software, which interprets the recorded data and ultimately helps the doctor in determining if the heart is getting adequate oxygen and diagnosing conditions related to irregular cardiac rhythms including arrhythmia, tachycardia and atrial fibrillation. These attributes of holter monitors in confluence with the rising incidences of cardiac issues among individuals are fueling their demand across the globe.

Owing to rapid urbanization, hectic work schedules and increasing consumption of fast food, a rise in the prevalence of cardiac blockages and arrests have been witnessed globally. This has increased the demand for technologically advanced devices that help in diagnosing health problems accurately. Moreover, governments in numerous countries are funding to create more awareness among individuals about different cardiovascular disorders, their prevention and treatment. Further, a significant shift toward minimally invasive diagnostic tools and preventive healthcare devices among individuals is strengthening the market growth. In line with this, manufacturers are introducing innovative and miniaturized products that offer enhanced convenience. For instance, iRhythm Technologies, a digital healthcare company, has introduced Zio Patch which incorporates the holter monitor into a small pedometer-sized device with an adhesive backing. Similarly, DMS Service has developed MyPatch Holter device that weighs less than a pound and can be stuck to the sternum of the patient, thereby eliminating the need for wires.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac holter monitor market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, component and end user.

Breakup by Product Type:

1-Channel
2-Channel
3-Channel
12-Channel
Others

Breakup by Component:

Holter Monitoring Devices
Event Monitoring Devices
Holter Analysis System and Software

Breakup by End User:

Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Homecare
Others

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being The ScottCare Corporation, GE Healthcare, Spacelabs Healthcare, Fukuda Denshi Co., Ltd., Nasiff Associates, Inc., Koninklijke Philips N.V., Biomedical Instruments Co., Ltd., Schiller, BTL, LifeWatch AG, Welch Allyn, Nihon Kohden Corporation, Medtronic Plc, Hill-Rom Company, Inc., Mindray Medical International Limited, BPL Medical Technologies, etc.

Key Questions Answered in This Report
1. What was the size of the global cardiac holter monitor market in 2022?
2. What is the expected growth rate of the global cardiac holter monitor market during 2023-2028?
3. What are the key factors driving the global cardiac holter monitor market?
4. What has been the impact of COVID-19 on the global cardiac holter monitor market?
5. What is the breakup of the global cardiac holter monitor market based on the product type?
6. What is the breakup of the global cardiac holter monitor market based on the component?
7. What is the breakup of the global cardiac holter monitor market based on the end user?
8. What are the key regions in the global cardiac holter monitor market?
9. Who are the key players/companies in the global cardiac holter monitor market?

■ 英語タイトル：Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0193 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：112 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global cardiac biomarkers market size reached US$ 9.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.42% during 2023-2028.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type, location of testing, and application.

Breakup by Type:

Troponins (T and I)
Myocardial Muscle Creatine Kinase (CK-MB)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia Modified Albumin (IMA)
Others

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Breakup by Location of Testing:

Laboratory Testing
Point of Care Testing

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

North America
Asia Pacific
Europe
Middle East and Africa
Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key Questions Answered in This Report
1. What was the size of the global cardiac biomarkers market in 2022?
2. What is the expected growth rate of the global cardiac biomarkers market during 2023- 2028?
3. What are the key factors driving the global cardiac biomarkers market?
4. What has been the impact of COVID-19 on the global cardiac biomarkers market?
5. What is the breakup of the global cardiac biomarkers market based on the location of testing?
6. What is the breakup of the global cardiac biomarkers market based on the application?
7. What are the key regions in the global cardiac biomarkers market?
8. Who are the key companies/players in the global cardiac biomarkers market?

■ 英語タイトル：Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0183 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：106 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global breast pump market size reached US$ 905.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,382.3 Million by 2028, exhibiting a growth rate (CAGR) of 7.12% during 2023-2028. The growing rate of employment opportunities for women, increasing demand for breast milk in milk banks for premature babies, and rising advancements in the functionalities of breast pumps represent some of the key factors driving the market.

A breast pump is a medical device that facilitates the extraction of milk from lactating mothers. It relieves mastitis, helps in overcoming inverted or flat nipples and prevents discomfort, engorgement, and the risk of developing breast infection. It enables mothers to breastfeed their infants at a convenient time and store milk for later. It also aids in providing breastmilk to premature babies kept in neonatal intensive care units (NICU) or donating breastmilk to feed babies of non-lactating mothers. Besides this, it assists in stimulating lactation in mothers with low milk production and feeding babies incapable of latching properly. Presently, the demand for breast pumps is rising around the world on account of the increasing healthcare expenditure and easy access to medical devices.

Global Breast Pump Market Trends:
At present, the increasing demand for breast pumps among nursing mothers for hands-free pumping represents one of the primary factors influencing the market positively. Besides this, the growing availability of employment opportunities for women in various industry verticals are offering a favorable market outlook. In addition, the escalating demand for breast milk in milk banks for supplying at hospitals to feed premature babies incapable of tolerating artificial feeding formulas is propelling the growth of the market. Apart from this, the rising awareness about the benefits of feeding breast milk to babies for proper development of bones and brain, boosting the immune system, and lowering the risk of infections is supporting the growth of the market. Additionally, the increasing integration of compression mechanisms in breast pumps to increase the efficacy of the device and maintain a continuous flow of breast milk is strengthening the growth of the market. Moreover, the rising utilization of closed breast pumps to prevent contamination and retain the quality of extracted milk is contributing to the growth of the market. Furthermore, key market players are developing breast pumps that can fit inside a nursing bra and operate via smartphones for extracting milk discreetly. They are also manufacturing eco-friendly breast pumps and storage containers to maintain the quality of milk and reduce the usage of plastics, which is expected to bolster the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast pump market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type, technology and application.

Type Insights:

Closed System Breast Pump
Open System Breast Pump

The report has provided a detailed breakup and analysis of the breast pump market based on the type. This includes closed system breast pump and open system breast pump. According to the report, closed system breast pump represented the largest segment.

Technology Insights:

Battey-Powered Breast Pump
Electric Breast Pump
Manual Breast Pump

A detailed breakup and analysis of the breast pump market based on technology has also been provided in the report. This includes battery-powered breast pump, electric breast pump and manual breast pump. According to the report, battery-powered accounted for the largest market share.

Application Insights:

Hospital
Personal Care

A detailed breakup and analysis of the breast pump market based on the application has also been provided in the report. This includes hospital and personal care. According to the report, hospital accounted for the largest market share.

Regional Insights:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to the report, North America was the largest market for breast pumps. Some of the factors driving the North America breast pump market included the growing awareness about the benefits of breast pumps, increasing employment of women, rising healthcare expenditure etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global breast pump market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Philips Avent, Pigeon Corporation, Medela AG, Ameda Inc and Hygeia Medical Group II. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report
1. What was the size of the global breast pump market in 2022?
2. What is the expected growth rate of the global breast pump market during 2023-2028?
3. What are the key factors driving the global breast pump market?
4. What has been the impact of COVID-19 on the global breast pump market?
5. What is the breakup of the global breast pump market based on the type?
6. What is the breakup of the global breast pump market based on the technology?
7. What is the breakup of the global breast pump market based on the application?
8. What are the key regions in the global breast pump market?
9. Who are the key players/companies in the global breast pump market?

■ 英語タイトル：Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0182 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：143 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global breast lesion localization methods market size reached US$ 1,102.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,018.5 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:
A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, usage and end user.

Breakup by Type:

Wire Localization
Radioisotope Localization
Magnetic Tracers Localization
Others

Breakup by Usage:

Tumor Identification
Sentinel Lymph Node Identification
Lumpectomy
Mastectomy

Breakup by End User:

Hospitals
Diagnostic Centres
Oncology Clinics
Ambulatory Surgical Centers

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report
1. What was the size of the global breast lesion localization methods market in 2022?
2. What is the expected growth rate of the global breast lesion localization methods market during 2023-2028?
3. What are the key factors driving the global breast lesion localization methods market?
4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
5. What is the breakup of the global breast lesion localization methods market based on type?
6. What is the breakup of the global breast lesion localization methods market based on the usage?
7. What is the breakup of the global breast lesion localization methods market based on the end user?
8. What are the key regions in the global breast lesion localization methods market?
9. Who are the key players/companies in the global breast lesion localization methods market?

■ 英語タイトル：Breast Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23FB0181 ■ 発行日：2023年2月1日 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：145 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

The global breast implant market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028.

Breast implants refer to a prosthesis device, which is formulated from the silicon outer shell that is stuffed with a blend of silicone gel and saline. This process is extensively deployed in cosmetic surgery for enhancing and changing the size, shape, and contour of the breast by replacing and removing tissue. Breast implants surgery includes anesthesia, incision, insertion, placement, and closing of the devices with layered sutures or surgical tape in the breast tissue. At present, the breast implant is commercially available in varying types, such as saline, silicone, structured, gummy bear, round, textured and smooth breast implants.

Breast Implant Market Trends:
The increasing demand for breast implantation and cosmetic surgeries, along with the rising inclination of consumers toward maintaining an aesthetic appeal, is one of the key factors influencing the global breast implant market growth. Additionally, the escalating prevalence of breast cancer is fueling the market growth, as these implants are used in breast reconstruction procedures among patients. Moreover, the introduction of technologically advanced hyaluronic acid fillers and stable silicone gel breast implants for offering better resemblance to natural breast tissue is contributing to the market growth. In line with this, the widespread adoption of composite breasts is another growth-inducing factor. Furthermore, continual product launches and collaborations of various brands to sensitize the target audience about the post-surgery complications and associated risks is promoting the breast implant market growth. Various organizations are also forming partnership agreements for developing advanced breast implants using the 3D printing technology. Other factors, including rapid technological advancements, are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, shape, application and end user.

Breakup by Product:

Silicone Breast Implants
Saline Breast Implants

Breakup by Shape:

Round
Anatomical

Breakup by Application:

Cosmetic Surgery
Reconstructive Surgery

Breakup by End User:

Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc, CEREPLAS, Establishment Labs SA, Global Consolidated Aesthetics Limited, Groupe Sebbin SAS, HansBiomed Co. Ltd., Ideal Implant Inc., Laboratoires Arion, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH and Sientra Inc.

Key Questions Answered in This Report
1. What was the size of the global breast implant market in 2022?
2. What is the expected growth rate of the global breast implant market during 2023-2028?
3. What are the key factors driving the global breast implant market?
4. What has been the impact of COVID-19 on the global breast implant market?
5. What is the breakup of the global breast implant market based on the product?
6. What is the breakup of the global breast implant market based on the application?
7. What is the breakup of the global breast implant market based on the end user?
8. What are the key regions in the global breast implant market?
9. Who are the key players/companies in the global breast implant market?